Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$0.40
-9.1%
$0.44
$0.32
$0.75
$20.30M-0.11203,330 shs89,135 shs
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
$0.02
$0.01
$0.05
N/AN/A63,600 shs37,900 shs
ANGHW
Anghami
$0.03
$0.06
$0.01
$0.11
N/AN/A8,351 shsN/A
Bally Technologies stock logo
BYI
Bally Technologies
$0.00
$56.50
$84.66
N/AN/A839,983 shsN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
$0.77
$0.84
$0.72
$1.63
N/AN/A64,615 shs27,313 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-1.20%+3.91%-14.98%+3.93%-10.62%
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
0.00%0.00%0.00%0.00%0.00%
ANGHW
Anghami
0.00%-24.10%-60.63%+13.72%-47.50%
WildBrain Ltd. stock logo
WLDBF
WildBrain
0.00%+1.01%-13.73%-20.76%-48.81%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/AN/AN/AN/A
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/AN/AN/AN/AN/AN/A
ANGHW
Anghami
N/AN/AN/AN/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/A
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/AN/A
ANGHW
Anghami
N/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/A$3.00290.73% Upside

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$202K100.50N/AN/A$0.20 per share2.00
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/AN/AN/AN/A
ANGHW
Anghami
$41.38MN/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/AN/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$28.96M-$0.60N/AN/A-14,337.62%-121.69%-97.91%5/13/2024 (Estimated)
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/A0.00N/AN/AN/AN/AN/AN/A
ANGHW
Anghami
N/AN/A0.00N/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/A0.00N/AN/AN/AN/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/A0.00N/AN/AN/AN/A5/10/2024 (Estimated)

Latest WLDBF, AIM, ANGHW, AMEFF, and BYI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/29/2024Q4 2023
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A-$0.26-$0.26-$0.26N/A$0.07 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/AN/AN/A
ANGHW
Anghami
N/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A
1.68
1.68
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/A
ANGHW
Anghami
N/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
12.02%
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/A
ANGHW
Anghami
N/A
Bally Technologies stock logo
BYI
Bally Technologies
N/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/A

Insider Ownership

CompanyInsider Ownership
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.02%
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/A
ANGHW
Anghami
N/A
Bally Technologies stock logo
BYI
Bally Technologies
N/A
WildBrain Ltd. stock logo
WLDBF
WildBrain
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
2650.75 million50.74 millionNot Optionable
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/ANot Optionable
ANGHW
Anghami
143N/AN/ANot Optionable
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/ANot Optionable
WildBrain Ltd. stock logo
WLDBF
WildBrain
613N/AN/ANot Optionable

WLDBF, AIM, ANGHW, AMEFF, and BYI Headlines

SourceHeadline
Hold Rating on WildBrain Amid Revenue Decline and Financial ChallengesHold Rating on WildBrain Amid Revenue Decline and Financial Challenges
markets.businessinsider.com - May 10 at 9:43 PM
WILDBRAIN REPORTS Q3 2024 RESULTSWILDBRAIN REPORTS Q3 2024 RESULTS
prnewswire.com - May 9 at 9:51 PM
WILDBRAIN ANNOUNCES CONFERENCE CALL FOR ITS FISCAL 2024 Q3 RESULTSWILDBRAIN ANNOUNCES CONFERENCE CALL FOR ITS FISCAL 2024 Q3 RESULTS
prnewswire.com - May 1 at 8:00 AM
WildBrain Ltd WLDBFWildBrain Ltd WLDBF
morningstar.com - April 17 at 12:49 AM
Online AuctionsOnline Auctions
nhl.com - March 26 at 12:53 AM
WILDBRAINS STRAWBERRY SHORTCAKE LAUNCHES MORE EXCITING FASHION, ACCESSORIES & COLLECTIBLES COLLABORATIONS FOR SPRING AS HER 45TH ANNIVERSARY CELEBRATIONS HEAT UPWILDBRAIN'S STRAWBERRY SHORTCAKE LAUNCHES MORE EXCITING FASHION, ACCESSORIES & COLLECTIBLES COLLABORATIONS FOR SPRING AS HER 45TH ANNIVERSARY CELEBRATIONS HEAT UP
prnewswire.com - March 20 at 9:00 AM
WILDBRAINS STRAWBERRY SHORTCAKE CELEBRATES HER 45TH ANNIVERSARY IN COLLABORATION WITH BAKERS, MAKERS AND CREATORSWILDBRAIN'S STRAWBERRY SHORTCAKE CELEBRATES HER 45TH ANNIVERSARY IN COLLABORATION WITH BAKERS, MAKERS AND CREATORS
finance.yahoo.com - February 15 at 9:40 AM
WILDBRAINS STRAWBERRY SHORTCAKE CELEBRATES HER 45TH ANNIVERSARY IN COLLABORATION WITH BAKERS, MAKERS AND CREATORSWILDBRAIN'S STRAWBERRY SHORTCAKE CELEBRATES HER 45TH ANNIVERSARY IN COLLABORATION WITH BAKERS, MAKERS AND CREATORS
prnewswire.com - February 15 at 9:00 AM
WildBrain GAAP EPS of C$0.02, revenue of C$126.3M; updates FY24 guidanceWildBrain GAAP EPS of C$0.02, revenue of C$126.3M; updates FY24 guidance
msn.com - February 9 at 6:28 AM
Investors in WildBrain (TSE:WILD) from a year ago are still down 57%, even after 12% gain this past weekInvestors in WildBrain (TSE:WILD) from a year ago are still down 57%, even after 12% gain this past week
finance.yahoo.com - January 9 at 8:28 AM
WILDBRAINS STRAWBERRY SHORTCAKE BRINGING THE SWEETEST HOLIDAY SPIRIT TO THE CANDY COTTAGE OF CHRISTMAS MAGIC AT ROCKEFELLER CENTERWILDBRAIN'S STRAWBERRY SHORTCAKE BRINGING THE SWEETEST HOLIDAY SPIRIT TO THE CANDY COTTAGE OF CHRISTMAS MAGIC AT ROCKEFELLER CENTER
finance.yahoo.com - November 16 at 7:52 AM
WildBrain GAAP EPS of -C$0.08, revenue of C$105.5MWildBrain GAAP EPS of -C$0.08, revenue of C$105.5M
seekingalpha.com - November 8 at 5:28 AM
Stock Index Futures Slip as Investors Brace for U.S. Inflation Data, Oracle Results DisappointStock Index Futures Slip as Investors Brace for U.S. Inflation Data, Oracle Results Disappoint
theglobeandmail.com - September 12 at 7:29 AM
Guest Chef TakeoverGuest Chef Takeover
nhl.com - August 30 at 11:24 PM
Parenting NewsParenting News
sciencedaily.com - August 29 at 9:43 PM
Parts of the BrainParts of the Brain
education.com - August 27 at 11:31 PM
Brain teaser: Play detective and identify the man’s real wife in 10 secondsBrain teaser: Play detective and identify the man’s real wife in 10 seconds
timesofindia.indiatimes.com - August 25 at 11:14 PM
Psychology NewsPsychology News
sciencedaily.com - August 22 at 3:15 PM
Addiction NewsAddiction News
sciencedaily.com - August 21 at 11:58 PM
WildBrain Ltd (Common & Variable Voting)WildBrain Ltd (Common & Variable Voting)
thestreet.com - August 9 at 10:34 AM
WILDWILD
npr.org - July 11 at 12:35 AM
WildBrain Ltd (WILD) NPVWildBrain Ltd (WILD) NPV
hl.co.uk - March 18 at 9:41 AM
Analysts Offer Insights on Services Companies: WildBrain (OtherWLDBF) and Walt Disney (DIS)Analysts Offer Insights on Services Companies: WildBrain (OtherWLDBF) and Walt Disney (DIS)
markets.businessinsider.com - February 10 at 9:12 PM
WILDBRAIN ANNOUNCES CONFERENCE CALL FOR ITS FISCAL 2023 Q2 RESULTSWILDBRAIN ANNOUNCES CONFERENCE CALL FOR ITS FISCAL 2023 Q2 RESULTS
ca.finance.yahoo.com - January 30 at 7:22 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

AIM ImmunoTech logo

AIM ImmunoTech

NYSE:AIM
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; Pharmaceutics International Inc.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
Appreciated Media logo

Appreciated Media

OTCMKTS:AMEFF
Appreciated Media Holdings, Inc. is a worldwide film and television media production packager. It engages in producing independent films, made-for-television movies, and TV series for global B2B distribution. The company was founded by Kirk Edward Shaw, Tony Zhang, and Norman Tsui on October 1, 2014 and is headquartered in Hamilton, Canada.

Anghami

NASDAQ:ANGHW
Anghami Inc. operates a digital music entertainment technology platform in the Middle East and North Africa. It offers digital entertainment and online streaming services, including music, podcasts, music videos, and live events; and a music application and platform that provides Arabic and international music to stream and download. The company was founded in 2012 and is headquartered in Abu Dhabi, the United Arab Emirates.
Bally Technologies logo

Bally Technologies

NYSE:BYI
Bally Technologies, Inc. (Bally) is a global gaming company, which designs, manufactures, operates, and distributes advanced technology-based gaming devices, systems, server-based solutions, custom mobile applications, and interactive applications. The Company also provides hardware, including spinning-reel and video gaming devices, specialty gaming devices, and wide-area progressive systems. The Company supports customers include land-based, riverboat, and Native American casinos, video lottery and central determination markets. The Company derives its revenue from sale of gaming devices and related equipment, parts and conversion kits; operation of linked progressive systems, video lottery and centrally determined systems, and the rental of gaming devices and content, and sale and support of specialized systems-based software, hardware and interactive products and related recurring maintenance revenue. In July 2014, Bally Technologies Inc acquired Dragonplay Ltd. (Dragonplay).
WildBrain logo

WildBrain

OTCMKTS:WLDBF
WildBrain Ltd. develops, produces, and distributes films and television programs in Canada, the United States, the United Kingdom, and internationally. The company operates through two segments, Content and Canadian Television Broadcasting. It focuses on children's and family content, including animated series; provides content production and distribution services; and operates children's ad-supported video-on-demand (AVOD) channels on YouTube and other AVOD platforms. The company also licenses rights of new proprietary series or pre-sells shows that are in development to individual streaming services, broadcasters, and other media platforms; and re-licenses rights of existing series in the library or packages of programs of its own proprietary titles, as well as third-party produced titles. In addition, it holds broadcast licenses for Family Channel, Family Jr., Télémagino, and WildBrain TV television channels; and operates as entertainment, sport, and brand licensing agency for the company's own and third party brands. Further, the company licenses its brands, such as Peanuts, Strawberry Shortcake, Chip and Potato, Teletubbies, Yo Gabba Gabba!, Caillou, Johnny Test, In the Night Garden, Mattel on Bob the Builder, Fireman Sam, Little People, Polly Pocket, Degrassi, and Inspector Gadget, as well as publishing, music rights, and live tours. Additionally, it offers its films and television programs for streaming services; and conventional and specialty terrestrial and cable/satellite television broadcasters, as well as for other media platforms and digital providers. The company was formerly known as DHX Media Ltd. and changed its name to WildBrain Ltd. in December 2019. WildBrain Ltd. was incorporated in 2004 and is headquartered in Toronto, Canada.